Visium HD is a spatial biology discovery tool that generates whole transcriptome data at single cell scale from FFPE, fresh frozen, and fixed frozen human and mouse tissues. It uses NGS-based spatial transcriptomics to map the molecular expression profiles of diverse cell types while preserving the complex spatial networks within tissue architecture.
The Mount Sinai Health System, one of New York City’s largest academic medical systems, announced the opening of the Hamilton and Amabel James Center for Artificial Intelligence and Human Health, which is dedicated to enhancing health care delivery through the research, development, and application of innovative artificial intelligence (AI) tools and technologies.
Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has introduced its external digital slide quality assessments to support laboratories in achieving good-quality histology slides—essential for accurate pathology diagnoses. Leveraging comprehensive, data-driven evaluations through AiosynQC Pulse, this service provides laboratories with insights to pinpoint common artifact issues, such as out-of-focus regions or tissue folds, improve digital slide quality, and comply with stringent quality requirements.
Owkin is proud to announce its participation in the 11th Digital Pathology & AI Congress: Europe, scheduled for December 11–12, 2024, at the Hilton London Metropole in London, UK. This esteemed event will convene leading professionals to explore the latest advancements in digital pathology and artificial intelligence.
Time seems to be an enemy to us all, even the cells that make up our bodies. Immune cells are a mysterious and incredibly important class of cells that protect us from pathogens, but normal aging processes can change their composition and function. These changes may hold the key to why certain diseases like arthritis generally appear with age or why the immune response weakens over time. And perhaps, if we define them, these patterns of change can be disrupted to improve human health in aging.
Novartis Ireland were delighted to recently mark its Collaboration Agreement with Deciphex, a Dublin-based digital pathology company, at a specially convened panel discussion on Artificial Intelligence (AI).
In a recent study, researchers at Wesleyan University (Connecticut, USA) and Gachon University Gil Hospital (Incheon, Republic of Korea) developed a deep learning framework to predict mismatch repair deficiency (MMR-D) status using digitized pathology slides from patients with endometrial cancer.
Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, was named to Fast Company’s fourth annual Next Big Things in Tech list honoring emerging technology that has profound impact for industries—from health and sustainability to robotics and artificial intelligence. Its Concentriq software platform was highlighted in the Health category.
PathAI, a global leader in AI-powered digital pathology solutions and the developer of the market-leading AISight1 Image Management System (IMS), today announced the integration of several AI products from market leading digital pathology companies, including Deep Bio, DoMore Diagnostics, Paige, and Visiopharm. Through these collaborations, PathAI will provide algorithms from these developers directly within its AISight IMS, reinforcing its commitment to offering the most versatile, reliable, and interoperable IMS on the market.
Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development, and diagnostics, and Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, have announced a strategic partnership to streamline MSI testing for patients with colorectal cancer (CRC), the second most deadly cancer worldwide[1].
